<DOC>
	<DOCNO>NCT02726139</DOCNO>
	<brief_summary>Commercial one two-stage factor VIII assay may detect clinically significant inhibitor antibody . The purpose propose study standardize validate platelet-based factor VIII activity assay great sensitivity clinically important inhibitory antibody . Investigators evaluate platelet-dependent inhibitory activity vs. conventional inhibitory activity store patient plasma correlate bleeding history</brief_summary>
	<brief_title>Improved Factor VIII Inhibitor Evaluation</brief_title>
	<detailed_description>Factor VIII activity assay use diagnose hemophilia A , monitor treatment patient , determine inhibitory antibody factor VIII develop , evaluate activity engineer pharmaceutical factor VIII product . Factor VIII activity measure one two-stage assay fifty year . However , exist assay major shortcoming recognize FDA , International Society Thrombosis Haemostasis , pharmaceutical company . The major deficiency identify : 1 ) Factor VIII activity level predict risk bleeding patient inhibitory antibody . The degree inhibition assay less required explain patient bleeding . 2 ) The assays accurate range 1 - 100 % normal factor VIII activity , value 0.1 - 1 % also clinically important . 3 ) The different approve assay give discrepant value recombinant pharmaceutical factor VIII product , range 2-fold difference assay . This lead clinically important difference dose factor VIII product one region another corresponding risk thrombosis bleeding . The preliminary data identify additional deficiency commercial assay anticipate . Commercial one two-stage assay may detect clinically significant inhibitor antibody . Thus , purpose propose study standardize validate platelet-based factor VIII activity assay great sensitivity clinically important inhibitory antibody .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>hemophilia A presence inhibitory antibody</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Factor VIII</keyword>
	<keyword>inhibitor</keyword>
	<keyword>assay</keyword>
</DOC>